![Aldeyra Therapeutics, Inc. Website Screenshot](https://storage.googleapis.com/wmc-assets-37ed7b3aea0e5732/UsersData/publicpages/id-239-date-2020-08-03.png)
http://www.aldeyra.com
Aldeyra Therapeutics, Inc. Company Intro
Learn more about Aldeyra Therapeutics, devoted to inventing, developing, and commercializing next-generation medicines that treat immune-mediated disease.
Industry
Healthcare
Aldeyra Therapeutics, Inc. Headquaters
131 Hartwell Avenue
Lexington,02421
United States
Aldeyra Therapeutics, Inc. Share price
17 May 2023 12:45 GMT
$10.07
-0.14 (-1.37 %)
Aldeyra Therapeutics, Inc. Market cap
$586.936 M
WMC RANKING
2024
Aldeyra Therapeutics, Inc. # 405
BiotechnologyLatest Aldeyra Therapeutics, Inc. News
10 Feb 2024
ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on ...
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential...
10 Feb 2024
ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on Behalf of Long-Term ...
ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to...
09 Feb 2024
Rapporto di ricerca sull'industria del trattamento dell'uveite anteriore (2023-2030) | Novartis AG, Santen Co., AbbVie ...
Il mercato Trattamento dell'uveite anteriore ha subito cambiamenti significativi negli ultimi anni, dovuti principalmente ai progressi tecnologici e al...
WMC Market Score
WMC Market to Revenue Score
Aldeyra Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Aldeyra Therapeutics, Inc. | USD | $0 | $35,859 | $-38,975 | $5,869M | 405 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aldeyra Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. Post vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aldeyra Therapeutics, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Aldeyra Therapeutics, Inc. | 0 | 1.08 | 0.00 | 0 | 0 | 0 | 0.38 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |